UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000032572
Receipt No. R000037144
Official scientific title of the study Transtympanic pressure treatment in patients with intractable Meniere's disease and delayed endolymphatic hydrops
Date of disclosure of the study information 2018/06/01
Last modified on 2018/05/13 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Transtympanic pressure treatment in patients with intractable Meniere's disease and delayed endolymphatic hydrops
Title of the study (Brief title) Trantympanic pressure treatment in Meniere's disease
Region
Japan

Condition
Condition Meniere's disease
Delayed endolymphatic hydrops
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effect of transtympanic pressure treatment to cure the intractable Meniere's disease and delayed endolymphatic hydorps.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Frequency of vertigo
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Pressure treatment using by the transtympanic massage device
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Intractable Meniere's disease and delayed endolymphatic hydrops
Key exclusion criteria Perforation of tympanic membrane
Target sample size 12

Research contact person
Name of lead principal investigator Hideo Shojaku
Organization University of Toyama
Division name Department of Otolaryngology
Address 2630 Sugitani, Toyama, Toyama
TEL 0764347368
Email hshojaku@med.u-toyama.ac.jp

Public contact
Name of contact person Hideo Shojaku
Organization University of Toyama
Division name Department of Otolaryngology
Address 2630 Sugitani, Toyama, Toyama
TEL 0764347368
Homepage URL
Email hshojaku@med.u-toyama.ac.jp

Sponsor
Institute University of Toyama
Institute
Department

Funding Source
Organization Self-raising
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 06 Month 01 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 08 Month 21 Day
Anticipated trial start date
2015 Year 09 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 05 Month 13 Day
Last modified on
2018 Year 05 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037144